Camex extends zero tariff for importing medicines and supplies to combat Covid-19

CAMEX (the chamber of foreign trade) extended the validity of Resolution No. 17/2020, which reduced the Import Tax rate to zero for products considered essential to combat the Covid-19 pandemic. The extension was approved at a virtual meeting of GECEX (the executive management committee of CAMEX), on December 18th, and published on December 29th in the Federal Register as GECEX Resolution 133/2020.

The exemption of the tax levy would have ended on December 31, 2020, but was extended until June 30, 2021 for 298 products, covering medicines and their inputs, tests for virus detection, and vaccines.

By maintaining exemption, the objective is to increase the supply of medicine and inputs for the national production of goods destined to fight the pandemic, reducing the costs for manufacturing these goods in the country and increasing their availability for the Brazilian health system.

Resolution 17/2020 also determines that the agencies and entities of the Federal Public Administration that perform licensing, control, or inspection of these imported items adopt priority treatment for the release of goods.

Sharing is caring!